Optivalue Tek (OPTIVALUE)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 54.90% indicates exceptional capital efficiency and a possible competitive advantage.
• Sales growth of 34.73% combined with a P/E of 12.39 gives a PEG of 0.51, suggesting attractive growth-adjusted valuation.
• Promoter holding of 64.07% aligns management interests with minority shareholders.
• Piotroski F-score of 7/9 points to sound financial fundamentals.
• Latest quarter shows ₹7 Cr net profit on ₹30 Cr sales, implying a strong margin.

Concerns

• Profit growth of 13.50% lags sales growth of 34.73%, indicating possible margin pressure or rising costs.
• No dividend and zero yield means investors get no income support while waiting.
• Lack of book value, ROE, and debt/equity data makes a full Graham-style balance sheet check impossible.
• Price has fallen sharply from the 52-week high of ₹176.45 to ₹78.15, showing real volatility and possible de-rating.

AI Analysis

Looking at Optivalue Tek, I'm reminded that a wonderful business can be bought at a fair price, and here the numbers make me pause and think. A P/E of 12.39 with sales growth of 34.73% and a PEG of 0.51 is the kind of arithmetic value investors should not ignore. But I have to separate the business from the quote. ROCE at 54.90% is exceptional; it suggests the company earns nearly ₹55 on every ₹100 of capital employed, which often points to a genuine competitive advantage or an asset-light model. Promoter holding at 64.07% aligns owners with shareholders. The Piotroski F-score of 7 out of 9 indicates decent financial health, though it is not perfect. Still, I see cracks. Profit growth of only 13.50% is far behind sales growth of 34.73%. In my experience, revenue that outruns earnings can mean pricing pressure, rising costs, or capital being put to work before it pays off. Without book value, debt/equity, or ROE data, I cannot judge the balance sheet or returns on equity with confidence. The 52-week range of ₹56.05 to ₹176.45 shows real volatility—this is not a steady compounder. And paying no dividend is fine if retained earnings earn high returns, but I need proof over time. Given a P/E of 12.39 and PEG of 0.51, the market is pricing in continued growth. The latest quarter's ₹30 Cr sales and ₹7 Cr profit show a strong margin, but one quarter is not a trend. I would want to see profit growth accelerate toward sales growth and more transparency on debt and book value. If management delivers, this could be a fast grower at a reasonable price. If not, the low multiple may be a value trap. I will keep it on my watchlist, not my buy list, until the fundamentals and disclosures match the price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer